功能肝脏影像评分(FLIS)可预测肝细胞癌患者的不良事件
本研究纳入150例因恶性肿瘤行肝切除并接受1.5 T钆塞酸增强MR检查的患者,评估FLIS预测术后肝衰竭(PHLF)和死亡的表现。在肝细胞癌(HCC)组中,FLIS与不良结局相关(HR=1.891,95%CI 1.772-3.471,p=0.039),预测不良结局的AUROC为0.660(95%CI 0.484-0.836),敏感度87%、特异度33.3%。作者认为FLIS有望用于术前识别有PHLF和死亡风险的患者。
要点
- 在HCC患者中,FLIS与术后不良结局独立相关(HR=1.891,95%CI 1.772-3.471,p=0.039)。
- FLIS预测不良结局的AUROC为0.660(95%CI 0.484-0.836),敏感度87%、特异度33.3%。
- 两位阅片者间FLIS相关评估的可靠性几乎完美(κ=0.998)。
核心结论
- FLIS可被视为术前识别有PHLF和死亡风险患者的有前景工具。
研究设计与样本
- 研究纳入150例连续接受肝切除及1.5 T钆塞酸增强MR检查的肝脏恶性肿瘤患者,其中HCC组58例(38.7%)、非HCC组92例(61.3%),由两位分别具有18年和8年腹部影像经验的放射科医生在不知临床数据的情况下评估EnQS、ExQS和PVsQs,采用Cohen's Kappa评估阅片者间可靠性,Cox回归分析确定与PHLF和OS相关的因素,并计算AUROC。
诊断标准与关键数值
- FLIS预测不良结局的AUROC为0.660(95%CI 0.484-0.836),敏感度87%(95%CI 81.1-94.4)、特异度33.3%(95%CI 22.1-42.1)。
- 两位阅片者间可靠性分析几乎完美(κ=0.998)。
临床应用与阅片要点
- 作者认为FLIS可被视为术前识别有PHLF和死亡风险患者的有前景工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the performance of FLIS in predicting adverse outcomes, namely post-hepatectomy liver failure (PHLF) and death, in patients who underwent liver surgery for malignancies.
METHODS: All consecutive patients who underwent liver resection and 1.5 T gadoxetic acid MR were enrolled. PHLF and overall survival (OS) were collected. Two radiologists with 18 and 8 years of experience in abdominal imaging, blinded to clinical data, evaluated all images. Radiologists evaluated liver parenchymal enhancement (EnQS), biliary contrast excretion (ExQS), and signal intensity of the portal vein relative to the liver parenchyma (PVsQs). Reliability analysis was computed with Cohen's Kappa. Cox regression analysis was calculated to determine which factors are associated with PHLF and OS. Area Under the Receiver Operating Characteristic curve (AUROC) was computed.
RESULTS: 150 patients were enrolled, 58 (38.7 %) in the HCC group and 92 (61.3 %) in the non-HCC group. The reliability analysis between the two readers was almost perfect (κ = 0.998). The multivariate Cox analysis showed that only post-surgical blood transfusions and major resection were associated with adverse events [HR=8.96 (7.98-9.88), p = 0.034, and HR=0.99 (0.781-1.121), p = 0.032, respectively] in the whole population. In the HCC group, the multivariable Cox analysis showed that blood transfusions, major resection and FLIS were associated with adverse outcomes [HR=13.133 (2.988-55.142), p = 0.009, HR=0.987 (0.244-1.987), p = 0.021, and HR=1.891 (1.772-3.471), p = 0.039]. The FLIS AUROC to predict adverse outcomes was 0.660 (95 %CIs = 0.484-0.836), with 87 % sensitivity and 33.3 % specificity (81.1-94.4 and 22.1-42.1).
CONCLUSIONS: FLIS can be considered a promising tool to preoperative depict patients at risk of PHLF and death.
引用
- Maino C, Romano F, Franco PN, et al. Functional liver imaging score (FLIS) can predict adverse events in HCC patients. Eur J Radiol. 2024. PMID: 39197273. doi:10.1016/j.ejrad.2024.111695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。